Sjs Investment Consulting Inc. Adma Biologics, Inc. Transaction History
Sjs Investment Consulting Inc.
- $567 Million
- Q2 2025
A detailed history of Sjs Investment Consulting Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Sjs Investment Consulting Inc. holds 12 shares of ADMA stock, worth $231. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12
Previous 71
83.1%
Holding current value
$231
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ADMA
# of Institutions
389Shares Held
190MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$360 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$326 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$249 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$221 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$110 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.8B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...